Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LOC101930420, also known as "primase, DNA, polypeptide 2 pseudogene", is a processed pseudogene: a DNA segment that resembles the functional DNA primase gene but has lost its protein-coding ability and is generally not expressed as a functional protein[1][7]. Pseudogenes may occasionally produce noncoding RNAs, such as lncRNAs or microRNA decoys, which can participate in gene regulation, though only a few are functionally characterized[5][6]. As a pseudogene, LOC101930420 is not directly involved in canonical biological pathways, does not encode a receptor, enzyme, or protein, and is not an established disease target or biomarker[1][7]. Its primary relevance is genomic annotation or population genetics rather than functional therapeutics. Key limitations and errors: This pseudogene is not a protein, receptor, enzyme, or functional gene product. It is not a therapeutic target and does not participate in pathways typical of canonical biological targets. The name could be misleading in therapeutic contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA primase large subunit-like pseudogene (LOC101930420).